The 29th Annual North American CF Conference Kicks Off in Phoenix

Today, more than 4,000 cystic fibrosis research scientists, clinicians and caregivers are gathering in Phoenix for the 29th Annual North American Cystic Fibrosis Conference (NACFC) in the largest collaborative forum of its kind. 

| 2 min read

Attendees from 42 different countries have come together to share the latest breakthroughs in CF care, treatment and drug development. Sponsored by the Cystic Fibrosis Foundation, NACFC marks an international effort to conquer CF and combat the daily challenge of living with the disease.

From October 8 through October 10, 2015, NACFC will feature three plenary presentations, a live one-on-one webcast and a variety of sessions addressing topics such as:

  • Personalized medicine as a powerful tool for addressing rare mutations in cystic fibrosis.
  • The integration of mental health as a critical component of specialized CF care, including the introduction of new screening and treatment guidelines for depression and anxiety.
  • Meeting the challenge of increasing participation of people with CF in clinical research as unprecedented numbers of clinical trials are underway worldwide.

As the largest CF-specific scientific conference, key sessions will be available to the CF community through online streaming. Notably, the Foundation will also be streaming a live one-on-one conversation between an adult with CF and mental health professional Anna Georgiopoulos, M.D., designed to address important questions surrounding the new guidelines for screening and treating depression and anxiety as part of CF care from the perspective of people with CF and their families.

To keep up with the latest NACFC updates, highlights and happenings, check out our CF Community Blog and follow us on Facebook or Twitter.

Share this article
About the CF Foundation | North American CF Conference
Recent news
CF Foundation Provides Up to $3.9M to TB Alliance to Further Develop an NTM Drug
News | 2 min read
CF Foundation Advocates to Protect Needs of People With CF in Post-Pandemic Medicaid Redeterminations
News | 5 min read
FDA Approves Kalydeco for Infants as Young as 1 Month
News | 4 min read
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.